Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Meta debuts Muse Spark, 1st AI model under Alexandr Wang

Digest more
Top News
Overview
 · 1h
Meta debuts Muse Spark multimodal reasoning model
Meta Platforms Inc. today debuted a new reasoning model, Muse Spark, that is highly adept at answering health questions and analyzing multimodal data.

Continue reading

 · 7h · on MSN
Meta's Muse Spark model brings reasoning capabilities to the Meta AI app
 · 4h · on MSN
Meta debuts the Muse Spark model in a 'ground-up overhaul' of its AI
 · 7h
Meta Unveils New A.I. Model, Its First From the Superintelligence Lab
Meta on Wednesday unveiled a new flagship artificial intelligence model called Muse Spark, its first under the revamped A.I. division that Mark Zuckerberg spent billions to build last year as the comp...

Continue reading

 · 8h
Meta is reentering the AI race with a new model called Muse Spark
 · 8h
Meta unveils first AI model from costly superintelligence team
6d

ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH

New data presented at ACC 2026 clarifies sotatercept’s role alongside vasodilator-based regimens in PAH patients.
European Medical Journal
6h

Whole-Body Cryotherapy Shows Promise in Ankylosing Spondylitis

Whole-body cryotherapy significantly improves pain, function, and disease activity in ankylosing spondylitis. Read more.
14d

Meta-analysis of nearly 15,000 people links IBS to low-grade inflammation signs

New research from the University of Newcastle has found that people with irritable bowel syndrome (IBS) show detectable biological changes, challenging the long-held perception that the condition lacks a physical basis.
6d

ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity

KOLs note that CagriSema could cannibalise semaglutide's market share in obesity due to its improved efficacy.
  • Privacy
  • Terms